PHASE I DOSE‐ESCALATION STUDY OF VENETOCLAX PLUS BEAM FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) FOR CHEMORESISTANT, RELAPSED/REFRACTORY, OR HIGH‐RISK NON‐HODGKIN'S LYMPHOMA (NHL); PRELIMINARY RESULTS. (12th June 2019)

• Record Type: Journal Article
• Authors: Maakaron, J.; Zhao, Q.; Puto, M.; Von Derau, R.; Robinson, J.; Brammer, J.; Penza, S.; Baiocchi, R.; Christian, B.; Maddocks, K.; Saad, A.; Wall, S.; Benson, D.; Efebera, Y.; Rosko, A.; Ayyappan, S.; Grieselhuber, N.; Vasu, S.; Larkin, K.; Epperla, N.; Devarakonda, S.; Choe, H.; Chaudhry, M.; Blaser, B.; Blachly, J.; Bhatnagar, B.; Alinari, L.; Mims, A.; Jaglowski, S.; William, B.M.
• Is Part Of: Hematological oncology. Volume 37(2019)Supplement 2
• Page Start: 528
• Page End: 529
• Publication Date: 2019-06-12
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.213_2631
• Languages: English
• ISSNs: 0278-0232